The widely available diabetes drug metformin may reduce the risk of emergency room visits, hospitalisation, and death from COVID-19 by more than half if taken within four days of the start of the symptoms, according to a study. The researchers from the University of Minnesota in the US noted that metformin, also known as Glucophage, has been used in the 1950s as an anti-viral called "Fluamine." In more recent research, the drug has been found to affect inflammation pathways, they said. Since COVID-19 involves viral inflammation, the research team thought the combination of anti-inflammatory plus antiviral action was intriguing enough to test the drug. "This was really intriguing to us early
Hence then, the article about us study finds diabetes drug metformin may reduce covid death risk by half was published today ( ) and is available onBusiness Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( US study finds diabetes drug metformin may reduce Covid death risk by half )